Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.
2.

Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.

Boutlis CS, Hobbs MR, Marsh RL, Misukonis MA, Tkachuk AN, Lagog M, Booth J, Granger DL, Bockarie MJ, Mgone CS, Levesque MC, Weinberg JB, Anstey NM.

Am J Trop Med Hyg. 2003 Dec;69(6):569-73.

PMID:
14740870
3.

Plasma interleukin-12 in malaria-tolerant papua new guineans: inverse correlation with Plasmodium falciparum parasitemia and peripheral blood mononuclear cell nitric oxide synthase activity.

Boutlis CS, Lagog M, Chaisavaneeyakorn S, Misukonis MA, Bockarie MJ, Mgone CS, Wang Z, Morahan G, Weinberg JB, Udhayakumar V, Anstey NM.

Infect Immun. 2003 Nov;71(11):6354-7.

4.

Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults.

Boutlis CS, Tjitra E, Maniboey H, Misukonis MA, Saunders JR, Suprianto S, Weinberg JB, Anstey NM.

Infect Immun. 2003 Jul;71(7):3682-9.

5.

IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.

Levesque MC, Misukonis MA, O'Loughlin CW, Chen Y, Beasley BE, Wilson DL, Adams DJ, Silber R, Weinberg JB.

Leukemia. 2003 Feb;17(2):442-50.

PMID:
12592345
6.

Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway.

Fermor B, Weinberg JB, Pisetsky DS, Misukonis MA, Fink C, Guilak F.

Osteoarthritis Cartilage. 2002 Oct;10(10):792-8.

7.

Systemic nitric oxide production in human malaria. II. Analysis of mononuclear cell nitric oxide synthase type 2 antigen expression.

Saunders JR, Misukonis MA, Weinberg JB, Anstey NM.

Methods Mol Med. 2002;72:469-74. No abstract available.

PMID:
12125143
8.

Inducible nitric oxide synthase expression by peritoneal macrophages in endometriosis-associated infertility.

Osborn BH, Haney AF, Misukonis MA, Weinberg JB.

Fertil Steril. 2002 Jan;77(1):46-51.

PMID:
11779590
9.

Host response to infection: the role of CpG DNA in induction of cyclooxygenase 2 and nitric oxide synthase 2 in murine macrophages.

Ghosh DK, Misukonis MA, Reich C, Pisetsky DS, Weinberg JB.

Infect Immun. 2001 Dec;69(12):7703-10.

10.

The effects of static and intermittent compression on nitric oxide production in articular cartilage explants.

Fermor B, Weinberg JB, Pisetsky DS, Misukonis MA, Banes AJ, Guilak F.

J Orthop Res. 2001 Jul;19(4):729-37.

11.

Characterization of key residues in the subdomain encoded by exons 8 and 9 of human inducible nitric oxide synthase: a critical role for Asp-280 in substrate binding and subunit interactions.

Ghosh DK, Rashid MB, Crane B, Taskar V, Mast M, Misukonis MA, Weinberg JB, Eissa NT.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10392-7. Epub 2001 Aug 21.

12.

The effect of dynamic mechanical compression on nitric oxide production in the meniscus.

Fink C, Fermor B, Weinberg JB, Pisetsky DS, Misukonis MA, Guilak F.

Osteoarthritis Cartilage. 2001 Jul;9(5):481-7.

13.

Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria.

Levesque MC, Hobbs MR, Anstey NM, Vaughn TN, Chancellor JA, Pole A, Perkins DJ, Misukonis MA, Chanock SJ, Granger DL, Weinberg JB.

J Infect Dis. 1999 Dec;180(6):1994-2002. Erratum in: J Infect Dis 2000 Jan;181(1):408.

PMID:
10558957
14.

Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria.

Perkins DJ, Kremsner PG, Schmid D, Misukonis MA, Kelly MA, Weinberg JB.

Infect Immun. 1999 Sep;67(9):4977-81.

15.

Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2).

Perkins DJ, St Clair EW, Misukonis MA, Weinberg JB.

Arthritis Rheum. 1998 Dec;41(12):2205-10.

PMID:
9870877
17.

Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2.

Gilkeson GS, Mudgett JS, Seldin MF, Ruiz P, Alexander AA, Misukonis MA, Pisetsky DS, Weinberg JB.

J Exp Med. 1997 Aug 4;186(3):365-73.

18.

Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients.

St Clair EW, Wilkinson WE, Lang T, Sanders L, Misukonis MA, Gilkeson GS, Pisetsky DS, Granger DI, Weinberg JB.

J Exp Med. 1996 Sep 1;184(3):1173-8.

19.

Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression.

Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Manyenga D, Misukonis MA, Arnelle DR, Hollis D, McDonald MI, Granger DL.

J Exp Med. 1996 Aug 1;184(2):557-67.

20.

Inhibition of productive human immunodeficiency virus-1 infection by cobalamins.

Weinberg JB, Sauls DL, Misukonis MA, Shugars DC.

Blood. 1995 Aug 15;86(4):1281-7.

21.

Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells.

Shami PJ, Moore JO, Gockerman JP, Hathorn JW, Misukonis MA, Weinberg JB.

Leuk Res. 1995 Aug;19(8):527-33.

PMID:
7658698
22.

Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages.

Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman WA, Wood ER, Smith GK, McDonald B, Bachus KE, et al.

Blood. 1995 Aug 1;86(3):1184-95.

24.

Synovial mononuclear phagocytes in rheumatoid arthritis and osteoarthritis: quantitative and functional aspects.

Weinberg JB, Wortham TS, Misukonis MA, Patton KL, Chitneni SR.

Immunol Invest. 1993 Jul;22(5):365-74.

PMID:
8406626
25.

Evidence for indirect dietary regulation of cholecystokinin release in rats.

Sharara AI, Bouras EP, Misukonis MA, Liddle RA.

Am J Physiol. 1993 Jul;265(1 Pt 1):G107-12.

PMID:
8338159
26.

Calcium-dependent regulation of cholecystokinin secretion and potassium currents in STC-1 cells.

Mangel AW, Snow ND, Misukonis MA, Basavappa S, Middleton JP, Fitz JG, Liddle RA.

Am J Physiol. 1993 Jun;264(6 Pt 1):G1031-6.

PMID:
8333529
27.
28.

Role of calcium in monitor peptide-stimulated cholecystokinin release from perifused intestinal cells.

Bouras EP, Misukonis MA, Liddle RA.

Am J Physiol. 1992 May;262(5 Pt 1):G791-6.

PMID:
1590389
29.

Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function.

Conkling PR, Chua CC, Nadler P, Greenberg CS, Doty E, Misukonis MA, Haney AF, Bast RC Jr, Weinberg JB.

Cancer Res. 1988 Oct 1;48(19):5604-9.

31.
32.

Phenotypic characterization of gamma interferon-induced human monocyte polykaryons.

Weinberg JB, Hobbs MM, Misukonis MA.

Blood. 1985 Dec;66(6):1241-6.

33.
34.

Recombinant human gamma-interferon induces human monocyte polykaryon formation.

Weinberg JB, Hobbs MM, Misukonis MA.

Proc Natl Acad Sci U S A. 1984 Jul;81(14):4554-7.

35.
37.

Macrophages and infertility: oviductal macrophages as potential mediators of infertility.

Haney AF, Misukonis MA, Weinberg JB.

Fertil Steril. 1983 Mar;39(3):310-5.

PMID:
6681781

Supplemental Content

Loading ...
Support Center